<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurol Int</journal-id><journal-id journal-id-type="iso-abbrev">Neurol Int</journal-id><journal-id journal-id-type="publisher-id">NI</journal-id><journal-title-group><journal-title>Neurology International</journal-title></journal-title-group><issn pub-type="ppub">2035-8385</issn><issn pub-type="epub">2035-8377</issn><publisher><publisher-name>PAGEPress Publications, Pavia, Italy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26294941</article-id><article-id pub-id-type="pmc">4508540</article-id><article-id pub-id-type="doi">10.4081/ni.2015.5430</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Similar Effects of Two Modified Constraint-Induced Therapy Protocols on Motor Impairment, Motor Function and Quality of Life in Patients with Chronic Stroke</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Souza</surname><given-names>Wilma Costa</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Conforto</surname><given-names>Adriana B.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Orsini</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Stern</surname><given-names>Annette</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>André</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label><institution>Federal University of Rio de Janeiro, Rehabilitation Center of Rio de Janeiro</institution>, <addr-line>Brazil</addr-line></aff><aff id="aff002"><label>2</label><institution>Neurostimulation Laboratory, Hospital das Cĺinicas/São Paulo University</institution>, <addr-line>Brazil</addr-line></aff><aff id="aff003"><label>3</label>Neurology Department, <institution>Centro Universitário Augusto Mottta, UNISUAM, Bonsucesso</institution>, <addr-line>Brazil</addr-line></aff><aff id="aff004"><label>4</label>School of Psychology, <institution>University of Surrey</institution>, <addr-line>Guildford, UK</addr-line></aff><aff id="aff005"><label>5</label>Department of Neurology, <institution>School of Medicine, Federal University of Rio de Janeiro</institution>, <addr-line>Brazil</addr-line></aff><author-notes><corresp id="cor1">Programa de Pós-Graduação em Ciências da Reabilitação, Praça das Nações, 34, Bonsucesso, Rio de Janeiro, CEP: 21041021, Brasil. <email>orsinimarco@hotmail.com</email></corresp><fn fn-type="con"><p>Contributions: the authors contributed equally.</p></fn><fn fn-type="conflict"><p>Conflict of interest: the authors declare no potential conflict of interest.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><day>23</day><month>3</month><year>2015</year></pub-date><volume>7</volume><issue>1</issue><elocation-id>5430</elocation-id><history><date date-type="received"><day>09</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>03</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>©Copyright W. Costa Souza et al.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Licensee PAGEPress, Italy</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<uri xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</uri>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><offsets xml_i="4471" xml_f="5595" txt_i="11" txt_f="1135">Modified constraint-induced movement therapy (CIMT) protocols show motor function and real-world arm use improvement. Meanwhile it usually requires constant supervision by physiotherapists and is therefore more expensive than customary care. This study compared the preliminary efficacy of two modified CIMT protocols. A two-group randomized controlled trial with pre and post treatment measures and six months follow-up was conducted. Nineteen patients with chronic stroke received 10 treatment sessions distributed three to four times a week over 22 days. CIMT3h_direct group received 3 hours of CIMT supervised by a therapist (n=10) while CIMT1.5h_direct group had 1.5 hours of supervised CIMT+1.5 hours home exercises supervised by a caregiver (n=9). Outcome measures were the Fugl-Meyer Assessment, the Motor Activity Log, and the Stroke Specific Quality of Life Scale. The modified CIMT protocols were feasible and well tolerated. Improvements in motor function, real-world arm use and quality of life did not differ significantly between treated groups receiving either 3 or 1.5 hours mCIMT supervised by a therapist.</offsets></p></abstract><kwd-group><title>Key words</title><kwd>modified constraint-induced therapy</kwd><kwd>motor impairment and function</kwd><kwd>quality of life</kwd><kwd>stroke</kwd></kwd-group><counts><fig-count count="2"></fig-count><table-count count="1"></table-count><equation-count count="1"></equation-count><ref-count count="57"></ref-count><page-count count="6"></page-count></counts></article-meta></front><body><sec id="sec1-1"><title><offsets xml_i="6038" xml_f="6050" txt_i="1143" txt_f="1155">Introduction</offsets></title><p><offsets xml_i="6061" xml_f="6172" txt_i="1156" txt_f="1267">Global ageing is associated with an ever-increasing number of elderly individuals at increased risk for stroke.</offsets><sup><xref rid="ref1" ref-type="bibr"><offsets xml_i="6210" xml_f="6211" txt_i="1267" txt_f="1268">1</offsets></xref><offsets xml_i="6218" xml_f="6219" txt_i="1268" txt_f="1269">,</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="6252" xml_f="6253" txt_i="1269" txt_f="1270">2</offsets></xref></sup><offsets xml_i="6266" xml_f="6374" txt_i="1270" txt_f="1378"> Stroke is a condition with high incidence and mortality, and the most common cause of disability worldwide.</offsets><sup><xref rid="ref3" ref-type="bibr"><offsets xml_i="6412" xml_f="6413" txt_i="1378" txt_f="1379">3</offsets></xref></sup><offsets xml_i="6426" xml_f="6470" txt_i="1379" txt_f="1423"> Most strokes occur in developing countries,</offsets><sup><xref rid="ref4" ref-type="bibr"><offsets xml_i="6508" xml_f="6509" txt_i="1423" txt_f="1424">4</offsets></xref><offsets xml_i="6516" xml_f="6517" txt_i="1424" txt_f="1425">,</offsets><xref rid="ref5" ref-type="bibr"><offsets xml_i="6550" xml_f="6551" txt_i="1425" txt_f="1426">5</offsets></xref></sup><offsets xml_i="6564" xml_f="6606" txt_i="1426" txt_f="1468"> presenting a major burden to health care.</offsets></p><p><offsets xml_i="6613" xml_f="6719" txt_i="1469" txt_f="1575">In stroke patients, recovery of the upper limb is often limited when compared with that of the lower limb.</offsets><sup><xref rid="ref6" ref-type="bibr"><offsets xml_i="6757" xml_f="6758" txt_i="1575" txt_f="1576">6</offsets></xref></sup><offsets xml_i="6771" xml_f="6848" txt_i="1576" txt_f="1653"> Loss of upper limb function significantly contributes to overall disability.</offsets><sup><xref rid="ref7" ref-type="bibr"><offsets xml_i="6886" xml_f="6887" txt_i="1653" txt_f="1654">7</offsets></xref><offsets xml_i="6894" xml_f="6895" txt_i="1654" txt_f="1655">,</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="6928" xml_f="6929" txt_i="1655" txt_f="1656">8</offsets></xref></sup><offsets xml_i="6942" xml_f="7078" txt_i="1656" txt_f="1792"> Constraint-induced movement therapy (CIMT) is an evidence-based therapy for upper limb rehabilitation that evolved from basic research.</offsets><sup><xref rid="ref9" ref-type="bibr"><offsets xml_i="7116" xml_f="7117" txt_i="1792" txt_f="1793">9</offsets></xref><offsets xml_i="7124" xml_f="7125" txt_i="1793" txt_f="1794">,</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="7159" xml_f="7161" txt_i="1794" txt_f="1796">10</offsets></xref></sup><offsets xml_i="7174" xml_f="7375" txt_i="1796" txt_f="1997"> The original protocol involved training of the upper limb by shaping and task practice for 6 hours per day and constraint of the unaffected hand for approximately 90% of waking hours during two weeks.</offsets><sup><xref rid="ref10" ref-type="bibr"><offsets xml_i="7414" xml_f="7416" txt_i="1997" txt_f="1999">10</offsets></xref></sup><offsets xml_i="7429" xml_f="7525" txt_i="1999" txt_f="2095"> The effectiveness of CIMT in post-stroke patients has been shown by randomized clinical trials.</offsets><sup><xref rid="ref11" ref-type="bibr"><offsets xml_i="7564" xml_f="7569" txt_i="2095" txt_f="2100">11-13</offsets></xref></sup><offsets xml_i="7582" xml_f="7712" txt_i="2100" txt_f="2230"> CIMT improves real-world arm function significantly more than customary care, or no treatment, in the chronic phase after stroke.</offsets></p><p><offsets xml_i="7719" xml_f="7950" txt_i="2231" txt_f="2462">A limitation to widespread use of CIMT in stroke rehabilitation is that the original CIMT protocol requires constant supervision by physiotherapists during several hours per day, and is therefore more expensive than customary care.</offsets><sup><xref rid="ref14" ref-type="bibr"><offsets xml_i="7989" xml_f="7991" txt_i="2462" txt_f="2464">14</offsets></xref></sup><offsets xml_i="8004" xml_f="8297" txt_i="2464" txt_f="2757"> CIMT protocol is very difficult to implement under conditions of developing countries where most strokes occur. Modified CIMT protocols that include less time of direct supervision by a therapist would be more appropriate in developing countries that rely mostly on outpatient rehabilitation.</offsets></p><p><offsets xml_i="8304" xml_f="8367" txt_i="2758" txt_f="2821">In recent years, several studies adapted the original protocol,</offsets><sup><xref rid="ref6" ref-type="bibr"><offsets xml_i="8405" xml_f="8406" txt_i="2821" txt_f="2822">6</offsets></xref><offsets xml_i="8413" xml_f="8414" txt_i="2822" txt_f="2823">,</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="8448" xml_f="8453" txt_i="2823" txt_f="2828">15-19</offsets></xref></sup><offsets xml_i="8466" xml_f="8557" txt_i="2828" txt_f="2919"> and showed that modified protocols can also enhance motor function and real-world arm use.</offsets><sup><xref rid="ref19" ref-type="bibr"><offsets xml_i="8596" xml_f="8598" txt_i="2919" txt_f="2921">19</offsets></xref></sup><offsets xml_i="8611" xml_f="8727" txt_i="2921" txt_f="3037"> However results of modified protocols are conflicting. Supervised CIMT from 30 minutes to 3 hours over 10 sessions,</offsets><sup><xref rid="ref14" ref-type="bibr"><offsets xml_i="8766" xml_f="8771" txt_i="3037" txt_f="3042">14-18</offsets></xref></sup><offsets xml_i="8784" xml_f="8835" txt_i="3042" txt_f="3093"> led to enhancement of upper limb function in some,</offsets><sup><xref rid="ref15" ref-type="bibr"><offsets xml_i="8874" xml_f="8876" txt_i="3093" txt_f="3095">15</offsets></xref><offsets xml_i="8883" xml_f="8884" txt_i="3095" txt_f="3096">,</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="8918" xml_f="8920" txt_i="3096" txt_f="3098">18</offsets></xref></sup><offsets xml_i="8933" xml_f="8954" txt_i="3098" txt_f="3119"> but not all studies.</offsets><sup><xref rid="ref14" ref-type="bibr"><offsets xml_i="8993" xml_f="8995" txt_i="3119" txt_f="3121">14</offsets></xref><offsets xml_i="9002" xml_f="9003" txt_i="3121" txt_f="3122">,</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="9037" xml_f="9039" txt_i="3122" txt_f="3124">17</offsets></xref></sup></p><p><offsets xml_i="9059" xml_f="9488" txt_i="3125" txt_f="3554">The present study compares, in a public health facility in Brazil, the preliminary efficacy of two modified CIMT protocols, applied over ten sessions, with direct supervision provided by a therapist for either 3 or 1.5 hours. CIMT durations were based on feasibility of supervised treatment in middle- and low-income countries. The 3-hour supervised protocol was shown to be beneficial to upper limb function in previous studies,</offsets><sup><xref rid="ref14" ref-type="bibr"><offsets xml_i="9527" xml_f="9529" txt_i="3554" txt_f="3556">14</offsets></xref><offsets xml_i="9536" xml_f="9537" txt_i="3556" txt_f="3557">,</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="9571" xml_f="9573" txt_i="3557" txt_f="3559">17</offsets></xref></sup><offsets xml_i="9586" xml_f="9753" txt_i="3559" txt_f="3726"> while the 1.5 hour approach had not been previously tested. We hypothesized that both programs would lead to comparable changes in motor outcomes and quality of life.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="9816" xml_f="9837" txt_i="3728" txt_f="3749">Materials and Methods</offsets></title><sec id="sec2-1"><title><offsets xml_i="9869" xml_f="9881" txt_i="3750" txt_f="3762">Study design</offsets></title><p><offsets xml_i="9892" xml_f="10077" txt_i="3763" txt_f="3948">In this pilot, randomized, single-blinded clinical trial we compared the feasibility, safety, and efficacy of 10 sessions of either 3 hours of CI-therapy supervised by a therapist (CIMT</offsets><sub><offsets xml_i="10082" xml_f="10092" txt_i="3948" txt_f="3958">3h_direct)</offsets></sub><offsets xml_i="10098" xml_f="10199" txt_i="3958" txt_f="4059">, or 1.5 hours of supervised CI-therapy + 1.5 hours of home exercises supervised by a caregiver (CIMT</offsets><sub><offsets xml_i="10204" xml_f="10215" txt_i="4059" txt_f="4070">1.5h_direct</offsets></sub><offsets xml_i="10221" xml_f="10368" txt_i="4070" txt_f="4214">), in patients &gt;24 months after stroke. In both groups, patients were instructed to restrain the affected limb during waking hours, for 10 days.</offsets></p></sec><sec id="sec2-2"><title><offsets xml_i="10402" xml_f="10414" txt_i="4216" txt_f="4228">Participants</offsets></title><p><offsets xml_i="10425" xml_f="10495" txt_i="4229" txt_f="4299">Inclusion and exclusion criteria were based on previous CIMT research.</offsets><sup><xref rid="ref12" ref-type="bibr"><offsets xml_i="10534" xml_f="10536" txt_i="4299" txt_f="4301">12</offsets></xref></sup></p><p><italic><offsets xml_i="10564" xml_f="10582" txt_i="4302" txt_f="4320">Inclusion criteria</offsets></italic><offsets xml_i="10591" xml_f="11175" txt_i="4320" txt_f="4898">: age &gt;18 years; history of ischemic or hemorrhagic stroke leading to upper limb paresis in the previous 24 months; minimal active range of motion of 10 degrees for wrist extension, 10 degrees for abduction/extension of the thumb and at least 2 additional digits, 90 degrees for shoulder flexion and abduction, 45 degrees for shoulder external rotation, 30 degrees for elbow extension, 45 degrees for forearm supination and pronation (from neutral position), wrist extension (from neutral), and finger extension of all digits; amount-of-use score on the Motor Activity Log &gt;2.5;</offsets><sup><xref rid="ref9" ref-type="bibr"><offsets xml_i="11213" xml_f="11214" txt_i="4898" txt_f="4899">9</offsets></xref></sup><offsets xml_i="11227" xml_f="11502" txt_i="4899" txt_f="5174"> balance and stability to move using a glove in the unaffected hand; safe and independent transfer to toilet; ability to stand for two minutes with and without the glove (with support of upper limbs, if necessary); availability of a family member to supervise home exercises.</offsets></p><p><italic><offsets xml_i="11517" xml_f="11535" txt_i="5175" txt_f="5193">Exclusion criteria</offsets></italic><offsets xml_i="11544" xml_f="11629" txt_i="5193" txt_f="5275">: medical problems or cognitive deficit (mini mental status examination score &lt;24)</offsets><sup><xref rid="ref20" ref-type="bibr"><offsets xml_i="11668" xml_f="11670" txt_i="5275" txt_f="5277">20</offsets></xref></sup><offsets xml_i="11683" xml_f="12011" txt_i="5277" txt_f="5605"> that could interfere with study completion; aphasia or hemineglect; intended or actual participation in any other study; significant pain (≥4 in the visual analog scale) in any joint; upper limb treatment with anti-spasticity drugs in the previous 6 months; and severe upper limb spasticity (≥3 in the Modified Ashworth Scale).</offsets><sup><xref rid="ref21" ref-type="bibr"><offsets xml_i="12050" xml_f="12052" txt_i="5605" txt_f="5607">21</offsets></xref></sup></p><p><offsets xml_i="12072" xml_f="12316" txt_i="5608" txt_f="5852">The protocol was approved by the institutional review board for human studies of Federal University of Rio de Janeiro. Stroke patients were recruited in a public outpatient rehabilitation center and gave informed written consent to participate.</offsets></p></sec><sec id="sec2-3"><title><offsets xml_i="12350" xml_f="12367" txt_i="5854" txt_f="5871">Baseline measures</offsets></title><p><offsets xml_i="12378" xml_f="12518" txt_i="5872" txt_f="6012">The following characteristics were evaluated at baseline: gender, age, time from stroke, type of stroke, handedness and side of hemiparesis.</offsets></p></sec><sec id="sec2-4"><title><offsets xml_i="12552" xml_f="12571" txt_i="6014" txt_f="6033">Experimental design</offsets></title><p><offsets xml_i="12582" xml_f="12919" txt_i="6034" txt_f="6371">Patients were randomized to one of the two groups by a staff member not involved in the study. Randomization information was stored in sealed envelopes that were kept in a cabinet accessible solely to the principal investigator. Each patient received 10 treatment sessions distributed three to four times a week over 22 days. In the CIMT</offsets><sub><offsets xml_i="12924" xml_f="12935" txt_i="6371" txt_f="6382">1.5h_direct</offsets></sub><offsets xml_i="12941" xml_f="13628" txt_i="6382" txt_f="7069"> group, patients performed exercises with the paretic upper limb for 1.5 hours at an outpatient facility and home exercises, supervised by a caregiver or family member, for additional 1.5 hours. Two days before treatment started, the caregiver was trained for one hour by the researcher providing CIMT on how to supervise the prescribed exercises performed by the patient at home. Each caregiver was instructed to make notes in a log book about the exercises performed, the number of repetitions and difficulties experience by the patient. At the beginning of each session the homework was discussed and when necessary, the level of difficulty was increased or new tasks were prescribed.</offsets></p><p><offsets xml_i="13635" xml_f="13655" txt_i="7070" txt_f="7090">Patients in the CIMT</offsets><sub><offsets xml_i="13660" xml_f="13662" txt_i="7090" txt_f="7092">3h</offsets></sub><offsets xml_i="13668" xml_f="13669" txt_i="7092" txt_f="7093">_</offsets><sub><offsets xml_i="13674" xml_f="13680" txt_i="7093" txt_f="7099">direct</offsets></sub><offsets xml_i="13686" xml_f="13793" txt_i="7099" txt_f="7206"> group performed exercises under direct supervision of the same therapist that treated patients in the CIMT</offsets><sub><offsets xml_i="13798" xml_f="13802" txt_i="7206" txt_f="7210">1.5h</offsets></sub><offsets xml_i="13808" xml_f="13809" txt_i="7210" txt_f="7211">_</offsets><sub><offsets xml_i="13814" xml_f="13820" txt_i="7211" txt_f="7217">direct</offsets></sub><offsets xml_i="13826" xml_f="13885" txt_i="7217" txt_f="7276"> group for 3 hours per session, at the outpatient facility.</offsets></p><p><offsets xml_i="13892" xml_f="14010" txt_i="7277" txt_f="7395">In both groups, training was provided in an individual basis and consisted of shaping principles, as outlined by Taub </offsets><italic><offsets xml_i="14018" xml_f="14024" txt_i="7395" txt_f="7401">et al.</offsets></italic><offsets xml_i="14033" xml_f="14034" txt_i="7401" txt_f="7402">,</offsets><sup><xref rid="ref10" ref-type="bibr"><offsets xml_i="14073" xml_f="14075" txt_i="7402" txt_f="7404">10</offsets></xref><offsets xml_i="14082" xml_f="14083" txt_i="7404" txt_f="7405">,</offsets><xref rid="ref22" ref-type="bibr"><offsets xml_i="14117" xml_f="14119" txt_i="7405" txt_f="7407">22</offsets></xref></sup><offsets xml_i="14132" xml_f="14698" txt_i="7407" txt_f="7973"> and task specific practice. Shaping exercises comprised a battery of tasks including grasping and releasing objects of different shapes, playing cards and board games, clay activities, drawing and painting. Tasks were tailored to needs of each patient. Task-specific practice for both groups involved preparing a snack (sandwiches and juice), including arranging dishes and cutlery on a table, washing and drying them, and putting them in a cupboard. Treatment regimens were designed to ensure that both groups received the same amount of task practice and shaping.</offsets></p><p><offsets xml_i="14705" xml_f="15010" txt_i="7974" txt_f="8279">In both groups, patients were required to use a padded mitt in the unaffected hand at home, as much as possible during waking hours. The mitt prevented use of the unaffected hand to perform fine motor activities and should be used during activities of daily living (ADL) and household activities. The CIMT</offsets><sub><offsets xml_i="15015" xml_f="15026" txt_i="8279" txt_f="8290">1.5h_direct</offsets></sub><offsets xml_i="15032" xml_f="15334" txt_i="8290" txt_f="8592"> group received written assignment of practice at home. All patients were instructed to record the use time of the mitt and any difficulties perceived at home, in log books. At the beginning of each outpatient session the notes were discussed and, if necessary, problem-solving strategies were applied.</offsets></p></sec><sec id="sec2-5"><title><offsets xml_i="15368" xml_f="15385" txt_i="8594" txt_f="8611">Outcome measures </offsets><italic><offsets xml_i="15393" xml_f="15408" txt_i="8611" txt_f="8626">Primary outcome</offsets></italic></title><p><offsets xml_i="15428" xml_f="15489" txt_i="8627" txt_f="8688">The primary outcome measure was the Motor Activity Log (MAL).</offsets><sup><xref rid="ref9" ref-type="bibr"><offsets xml_i="15527" xml_f="15528" txt_i="8688" txt_f="8689">9</offsets></xref></sup><offsets xml_i="15541" xml_f="15617" txt_i="8689" txt_f="8765"> The MAL was developed to measure the use of the affected arm in real world,</offsets><sup><xref rid="ref23" ref-type="bibr"><offsets xml_i="15656" xml_f="15658" txt_i="8765" txt_f="8767">23</offsets></xref><offsets xml_i="15665" xml_f="15666" txt_i="8767" txt_f="8768">,</offsets><xref rid="ref24" ref-type="bibr"><offsets xml_i="15700" xml_f="15702" txt_i="8768" txt_f="8770">24</offsets></xref></sup><offsets xml_i="15715" xml_f="15898" txt_i="8770" txt_f="8953"> and consists of a semi-structured interview that can be applied to both patients and caregivers. It is capable of detecting phenomena not evaluated in other instruments, such as the </offsets><italic><offsets xml_i="15906" xml_f="15920" txt_i="8953" txt_f="8967">learned nonuse</offsets></italic><offsets xml_i="15929" xml_f="15930" txt_i="8967" txt_f="8968">.</offsets><sup><xref rid="ref24" ref-type="bibr"><offsets xml_i="15969" xml_f="15971" txt_i="8968" txt_f="8970">24</offsets></xref></sup><offsets xml_i="15984" xml_f="16149" txt_i="8970" txt_f="9135"> The present study applied the original version (14 activities) of the MAL quality of movement scale (QOM). Although the original instrument presents two subscales, </offsets><italic><offsets xml_i="16157" xml_f="16161" txt_i="9135" txt_f="9139">i.e.</offsets></italic><offsets xml_i="16170" xml_f="16371" txt_i="9139" txt_f="9340">, quality of movement (QOM) and amount of use (AOU), it has been shown that the QOM scale is able to capture components of both quality and quantity of use of the affected extremity in stroke patients.</offsets><sup><xref rid="ref25" ref-type="bibr"><offsets xml_i="16410" xml_f="16412" txt_i="9340" txt_f="9342">25</offsets></xref></sup><offsets xml_i="16425" xml_f="16651" txt_i="9342" txt_f="9568"> The MAL-14 presents a 5-point ordinal scale and individuals are asked to rate how well they have used the affected arm in the past week. Higher scores reflect great quality of movements of the more affected arm in real world.</offsets><sup><xref rid="ref25" ref-type="bibr"><offsets xml_i="16690" xml_f="16692" txt_i="9568" txt_f="9570">25</offsets></xref></sup></p><sec id="sec3-1"><title><offsets xml_i="16733" xml_f="16751" txt_i="9571" txt_f="9589">Secondary outcomes</offsets></title><p><offsets xml_i="16762" xml_f="16859" txt_i="9590" txt_f="9687">Secondary outcomes included the Fugl-Meyer Assessment of Sensorimotor Recovery after Stroke (FMA)</offsets><sup><xref rid="ref26" ref-type="bibr"><offsets xml_i="16898" xml_f="16903" txt_i="9687" txt_f="9692">26-28</offsets></xref></sup><offsets xml_i="16916" xml_f="16971" txt_i="9692" txt_f="9747"> and the Stroke Specific Quality of life Scale (SSQOL).</offsets><sup><xref rid="ref29" ref-type="bibr"><offsets xml_i="17010" xml_f="17015" txt_i="9747" txt_f="9752">29-31</offsets></xref></sup></p><p><offsets xml_i="17035" xml_f="17211" txt_i="9753" txt_f="9929">The FMA measures the level of motor impairment in stroke patients (best possible score for the upper limb, 66) and has excellent test-retest reliability and construct validity.</offsets></p><p><offsets xml_i="17218" xml_f="17434" txt_i="9930" txt_f="10146">The SSQOL assesses health-related quality of life in stroke patients and encompasses three dimensions of the International Classification of Functioning, Disability and Health: impairment, activity and participation.</offsets><sup><xref rid="ref31" ref-type="bibr"><offsets xml_i="17473" xml_f="17475" txt_i="10146" txt_f="10148">31</offsets></xref><offsets xml_i="17482" xml_f="17483" txt_i="10148" txt_f="10149">,</offsets><xref rid="ref32" ref-type="bibr"><offsets xml_i="17517" xml_f="17519" txt_i="10149" txt_f="10151">32</offsets></xref></sup><offsets xml_i="17532" xml_f="18123" txt_i="10151" txt_f="10742"> The instrument has proven its validity, reliability and sensitivity. It includes 49 items dealing with energy, family role, language, mobility, mood, personality, self-care, social role, reasoning, upper limb function, vision, and work/productivity. Each item is rated in a 5-point scale and the scale has a maximal score of 245 points with higher scores meaning better health-related quality of life. Outcomes were assessed at baseline, two days after the intervention program (end of treatment) and 6 months after end of treatment by a trained physiotherapist blinded to group assignment.</offsets></p></sec></sec><sec id="sec2-6"><title><offsets xml_i="18163" xml_f="18171" txt_i="10745" txt_f="10753">Analyses</offsets></title><p><offsets xml_i="18182" xml_f="18281" txt_i="10754" txt_f="10853">In order to compare treatment effects between the two groups, the Effectiveness Index – EI for MAL,</offsets><sup><xref rid="ref33" ref-type="bibr"><offsets xml_i="18320" xml_f="18322" txt_i="10853" txt_f="10855">33</offsets></xref></sup><offsets xml_i="18335" xml_f="18492" txt_i="10855" txt_f="11012"> FMA and SSQL was calculated in each group, comparing results before and post-treatment and before and 6 months after treatment using the following formula:
</offsets><disp-formula><graphic xlink:href="ni-2015-1-5430-e001.jpg" mime-subtype="tiff" position="float" orientation="portrait"></graphic></disp-formula></p><p><offsets xml_i="18644" xml_f="18926" txt_i="11013" txt_f="11295">The Effectiveness Index (EI) takes into account the fact that potential improvement for patients with high initial scores is lower than that for those with low initial scores. Thus, the EI reflects the proportion of potential improvement that was actually achieved during treatment.</offsets><sup><xref rid="ref34" ref-type="bibr"><offsets xml_i="18965" xml_f="18967" txt_i="11295" txt_f="11297">34</offsets></xref><offsets xml_i="18974" xml_f="18975" txt_i="11297" txt_f="11298">,</offsets><xref rid="ref35" ref-type="bibr"><offsets xml_i="19009" xml_f="19011" txt_i="11298" txt_f="11300">35</offsets></xref></sup></p><p><offsets xml_i="19031" xml_f="19276" txt_i="11301" txt_f="11546">After calculating the IE for each of the variables, Mann-Whitney U tests were applied to detect significant differences in treatment effects between the two groups, immediately after treatment and six months later (P≤0.025, Bonferroni correction</offsets><italic><offsets xml_i="19284" xml_f="19286" txt_i="11546" txt_f="11548">).</offsets></italic><offsets xml_i="19295" xml_f="19450" txt_i="11548" txt_f="11703"> Statistical analyses were performed using the Statistical Package for the Social Science (SPSS) version 17, software for Windows (SPSS, Chicago, IL, USA).</offsets></p></sec></sec><sec id="sec1-3"><title><offsets xml_i="19490" xml_f="19497" txt_i="11706" txt_f="11713">Results</offsets></title><p><offsets xml_i="19508" xml_f="19580" txt_i="11714" txt_f="11786">One hundred seventy four patients were screened and 24 were randomized (</offsets><xref ref-type="fig" rid="fig001"><offsets xml_i="19614" xml_f="19622" txt_i="11786" txt_f="11794">Figure 1</offsets></xref><offsets xml_i="19629" xml_f="19631" txt_i="11794" txt_f="11796">).</offsets></p><p><offsets xml_i="19638" xml_f="19717" txt_i="11797" txt_f="11876">Two patients in each group did not complete the treatment protocol. In the CIMT</offsets><sub><offsets xml_i="19722" xml_f="19733" txt_i="11876" txt_f="11887">1.5h_direct</offsets></sub><offsets xml_i="19739" xml_f="20038" txt_i="11887" txt_f="12186"> group, one patient moved far from the outpatient rehabilitation center and the other had financial limitations that impeded compliance with treatment three times a weak. One additional subject from this group had a fatal recurrent stroke before the last follow-up session at six months. In the CIMT</offsets><sub><offsets xml_i="20043" xml_f="20052" txt_i="12186" txt_f="12195">3h_direct</offsets></sub><offsets xml_i="20058" xml_f="20221" txt_i="12195" txt_f="12358"> group, one patient considered that the exercises were too difficult and the other one returned to work. Therefore, we analyzed data from nine patients in the CIMT</offsets><sub><offsets xml_i="20226" xml_f="20237" txt_i="12358" txt_f="12369">1.5h_direct</offsets></sub><offsets xml_i="20243" xml_f="20272" txt_i="12369" txt_f="12398"> and ten patients in the CIMT</offsets><sub><offsets xml_i="20277" xml_f="20286" txt_i="12398" txt_f="12407">3h_direct</offsets></sub><offsets xml_i="20292" xml_f="20299" txt_i="12407" txt_f="12414"> group.</offsets></p><p><xref ref-type="table" rid="table001"><offsets xml_i="20344" xml_f="20351" txt_i="12415" txt_f="12422">Table 1</offsets></xref><offsets xml_i="20358" xml_f="20554" txt_i="12422" txt_f="12618"> shows characteristics of the 19 subjects that completed the treatment and follow-up protocol. There were no significant differences in baseline characteristics between patients in the two groups.</offsets></p><p><offsets xml_i="20561" xml_f="20572" txt_i="12619" txt_f="12630">In the CIMT</offsets><sub><offsets xml_i="20577" xml_f="20588" txt_i="12630" txt_f="12641">1.5h_direct</offsets></sub><offsets xml_i="20594" xml_f="20678" txt_i="12641" txt_f="12725"> group, patients wore the mitt for an average of 3.3±1.5 daily hours and in the CIMT</offsets><sub><offsets xml_i="20683" xml_f="20692" txt_i="12725" txt_f="12734">3h_direct</offsets></sub><offsets xml_i="20698" xml_f="20763" txt_i="12734" txt_f="12799"> group, for 2.8±1.2 daily hours. However two patients in the CIMT</offsets><sub><offsets xml_i="20768" xml_f="20779" txt_i="12799" txt_f="12810">1.5h_direct</offsets></sub><offsets xml_i="20785" xml_f="20822" txt_i="12810" txt_f="12847"> group and three patients in the CIMT</offsets><sub><offsets xml_i="20827" xml_f="20836" txt_i="12847" txt_f="12856">3h_direct</offsets></sub><offsets xml_i="20842" xml_f="20892" txt_i="12856" txt_f="12906"> group did not log this information appropriately.</offsets></p><sec id="sec2-7"><title><offsets xml_i="20920" xml_f="20935" txt_i="12907" txt_f="12922">Primary outcome</offsets></title><p><xref ref-type="fig" rid="fig002"><offsets xml_i="20980" xml_f="20989" txt_i="12923" txt_f="12932">Figure 2A</offsets></xref><offsets xml_i="20996" xml_f="21371" txt_i="12932" txt_f="13307"> show results of EI for the MAL immediately after treatment and 6 months later. Immediately after treatment, there were no significant differences in EI results between the two groups (P=0.24). Likewise, no significant differences were observed between the groups, 6 months later (P=0.97), indicating comparable benefits from the two programs on real-life motor improvements.</offsets></p></sec><sec id="sec2-8"><title><offsets xml_i="21405" xml_f="21423" txt_i="13309" txt_f="13327">Secondary outcomes</offsets></title><p><offsets xml_i="21434" xml_f="21519" txt_i="13328" txt_f="13413">There were no significant differences in EI results regarding FMA scores between CIMT</offsets><sub><offsets xml_i="21524" xml_f="21528" txt_i="13413" txt_f="13417">1.5h</offsets></sub><offsets xml_i="21534" xml_f="21535" txt_i="13417" txt_f="13418">_</offsets><sub><offsets xml_i="21540" xml_f="21546" txt_i="13418" txt_f="13424">direct</offsets></sub><offsets xml_i="21552" xml_f="21571" txt_i="13424" txt_f="13443"> group and the CIMT</offsets><sub><offsets xml_i="21576" xml_f="21578" txt_i="13443" txt_f="13445">3h</offsets></sub><offsets xml_i="21584" xml_f="21585" txt_i="13445" txt_f="13446">_</offsets><sub><offsets xml_i="21590" xml_f="21596" txt_i="13446" txt_f="13452">direct</offsets></sub><offsets xml_i="21602" xml_f="21692" txt_i="13452" txt_f="13542"> group immediately after treatment (P=0.60). Similarly, no significant differences between</offsets></p><p><offsets xml_i="21699" xml_f="21703" txt_i="13543" txt_f="13547">CIMT</offsets><sub><offsets xml_i="21708" xml_f="21719" txt_i="13547" txt_f="13558">1.5h_direct</offsets></sub><offsets xml_i="21725" xml_f="21738" txt_i="13558" txt_f="13571"> and the CIMT</offsets><sub><offsets xml_i="21743" xml_f="21758" txt_i="13571" txt_f="13586">3h_direct·group</offsets></sub><offsets xml_i="21764" xml_f="21850" txt_i="13586" txt_f="13672"> after 6 months (P=0.84) indicating similar effects of therapies on motor impairment (</offsets><xref ref-type="fig" rid="fig002"><offsets xml_i="21884" xml_f="21893" txt_i="13672" txt_f="13681">Figure 2B</offsets></xref><offsets xml_i="21900" xml_f="21902" txt_i="13681" txt_f="13683">).</offsets></p></sec><sec id="sec2-9"><title><offsets xml_i="21936" xml_f="21951" txt_i="13685" txt_f="13700">Quality of life</offsets></title><p><xref ref-type="fig" rid="fig001"><offsets xml_i="21996" xml_f="22005" txt_i="13701" txt_f="13710">Figure 1C</offsets></xref><offsets xml_i="22012" xml_f="22171" txt_i="13710" txt_f="13869"> shows EI results. There were no significant differences between the two groups immediately after treatment (P=0.90) and at six months post-treatment (P=0.04).</offsets></p></sec></sec><sec id="sec1-4"><title><offsets xml_i="22211" xml_f="22237" txt_i="13872" txt_f="13898">Discussion and Conclusions</offsets></title><p><offsets xml_i="22248" xml_f="22641" txt_i="13899" txt_f="14292">In the present study, improvements in motor function, real-world arm use and quality of life did not differ significantly between treated groups receiving either 3 or 1.5 hours mCIMT supervised by a therapist. Results immediately after treatment and six months after that suggest that both protocols are equally efficient. Both groups had the same total training time (30 hours). However, CIMT</offsets><sub><offsets xml_i="22646" xml_f="22657" txt_i="14292" txt_f="14303">1.5h_direct</offsets></sub><offsets xml_i="22663" xml_f="22742" txt_i="14303" txt_f="14382"> group may be considered less expensive due to less demand on therapist’s time.</offsets></p><p><offsets xml_i="22749" xml_f="23001" txt_i="14383" txt_f="14635">All previous studies that addressed the effectiveness of unsupervised practice at home also suggested similar effectiveness of different versions of modified CIMT. Supervision for only 25 to 50% of the time was as effective as standard one-to-one CIMT.</offsets><sup><xref rid="ref36" ref-type="bibr"><offsets xml_i="23040" xml_f="23042" txt_i="14635" txt_f="14637">36</offsets></xref></sup><offsets xml_i="23055" xml_f="23256" txt_i="14637" txt_f="14838"> Likewise, similar gains in motor skill and real-world arm use were reported after and one hour of supervised outpatient practice coupled with 5 hours of unsupervised practice during two weeks at home.</offsets><sup><xref rid="ref37" ref-type="bibr"><offsets xml_i="23295" xml_f="23297" txt_i="14838" txt_f="14840">37</offsets></xref></sup><offsets xml_i="23310" xml_f="23497" txt_i="14840" txt_f="15027"> Furthermore, An exclusive home-based mCIMT program supervised by an instructed family member was equally effective as a totally supervised protocol and persisted for the next six months.</offsets><sup><xref rid="ref38" ref-type="bibr"><offsets xml_i="23536" xml_f="23538" txt_i="15027" txt_f="15029">38</offsets></xref></sup></p><p><offsets xml_i="23558" xml_f="23724" txt_i="15030" txt_f="15196">The development of flexible schedules may increase the number of treated patients. When questioned about their interest in participating in an original CIMT protocol,</offsets><sup><xref rid="ref39" ref-type="bibr"><offsets xml_i="23763" xml_f="23765" txt_i="15196" txt_f="15198">39</offsets></xref></sup><offsets xml_i="23778" xml_f="23970" txt_i="15198" txt_f="15390"> 68% of inquired patients said they were not interested because of concerns about the number of hours spent daily in therapy and the length of time required for wearing the restrictive device.</offsets></p><p><offsets xml_i="23977" xml_f="24084" txt_i="15391" txt_f="15498">In mCIMT studies, participants are typically requested to wear the constraint from five to six hours daily,</offsets><sup><xref rid="ref14" ref-type="bibr"><offsets xml_i="24123" xml_f="24125" txt_i="15498" txt_f="15500">14</offsets></xref><offsets xml_i="24132" xml_f="24133" txt_i="15500" txt_f="15501">,</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="24167" xml_f="24169" txt_i="15501" txt_f="15503">16</offsets></xref><offsets xml_i="24176" xml_f="24177" txt_i="15503" txt_f="15504">,</offsets><xref rid="ref40" ref-type="bibr"><offsets xml_i="24211" xml_f="24213" txt_i="15504" txt_f="15506">40</offsets></xref></sup><offsets xml_i="24226" xml_f="24254" txt_i="15506" txt_f="15534"> to 90% of the waking hours.</offsets><sup><xref rid="ref41" ref-type="bibr"><offsets xml_i="24293" xml_f="24298" txt_i="15534" txt_f="15539">41-43</offsets></xref></sup><offsets xml_i="24311" xml_f="24416" txt_i="15539" txt_f="15644"> Nevertheless, few studies reveal the real average number of daily hours with restraint in their results.</offsets><sup><xref rid="ref40" ref-type="bibr"><offsets xml_i="24455" xml_f="24457" txt_i="15644" txt_f="15646">40</offsets></xref><offsets xml_i="24464" xml_f="24465" txt_i="15646" txt_f="15647">,</offsets><xref rid="ref44" ref-type="bibr"><offsets xml_i="24499" xml_f="24501" txt_i="15647" txt_f="15649">44</offsets></xref></sup></p><p><offsets xml_i="24521" xml_f="24855" txt_i="15650" txt_f="15984">In the present study, besides the declared mitt time use, some patients informed they consciously avoided the use of the less affected arm in ADLs during the treatment period, so the actual restraint time is somewhat difficult to measure precisely. The contribution of the restraint component of CIMT is in fact not fully established.</offsets><sup><xref rid="ref45" ref-type="bibr"><offsets xml_i="24894" xml_f="24896" txt_i="15984" txt_f="15986">45</offsets></xref></sup><offsets xml_i="24909" xml_f="25069" txt_i="15986" txt_f="16146"> A mCIMT study with random assignment comparing protocols with and without restraint in 24 patients found similar motor improvements after a one-year follow-up.</offsets><sup><xref rid="ref46" ref-type="bibr"><offsets xml_i="25108" xml_f="25110" txt_i="16146" txt_f="16148">46</offsets></xref></sup><offsets xml_i="25123" xml_f="25139" txt_i="16148" txt_f="16164"> A recent study,</offsets><sup><xref rid="ref47" ref-type="bibr"><offsets xml_i="25178" xml_f="25180" txt_i="16164" txt_f="16166">47</offsets></xref></sup><offsets xml_i="25193" xml_f="25379" txt_i="16166" txt_f="16352"> evolving 47 participants, showed no difference between two groups of post stroke patients treated with a combination of CIMT and physiotherapy plus different constraint regimens (sling </offsets><italic><offsets xml_i="25387" xml_f="25393" txt_i="16352" txt_f="16358">versus</offsets></italic><offsets xml_i="25402" xml_f="25502" txt_i="16358" txt_f="16458"> voluntary constraint). It seems that using a sling were not an advantage over voluntary constraint.</offsets></p><p><offsets xml_i="25509" xml_f="25711" txt_i="16459" txt_f="16661">As to functional outcomes, the present study indicates a substantial improvement in real world arm use after intervention in both groups. In a partially supervised CIMT program based on Taub’s protocol,</offsets><sup><xref rid="ref37" ref-type="bibr"><offsets xml_i="25750" xml_f="25752" txt_i="16661" txt_f="16663">37</offsets></xref></sup><offsets xml_i="25765" xml_f="26188" txt_i="16663" txt_f="17083"> gains in MAL were lost six months after therapy. Training in the present study was less intensive (three hours a day) and distributed over a longer period of time (21 days). This may have contributed to retention of therapeutic gains in both groups of patients. MAL scores at the six-month follow-up exhibited significant improvements in both groups with total score &gt;2.5, indicating a perception of recovery above 50%.</offsets><sup><xref rid="ref48" ref-type="bibr"><offsets xml_i="26227" xml_f="26229" txt_i="17083" txt_f="17085">48</offsets></xref><offsets xml_i="26236" xml_f="26237" txt_i="17085" txt_f="17086">,</offsets><xref rid="ref49" ref-type="bibr"><offsets xml_i="26271" xml_f="26273" txt_i="17086" txt_f="17088">49</offsets></xref></sup><offsets xml_i="26286" xml_f="26409" txt_i="17088" txt_f="17211"> The MAL results in our study were consistent with those observed in another protocol with the same intensity and duration.</offsets><sup><xref rid="ref41" ref-type="bibr"><offsets xml_i="26448" xml_f="26450" txt_i="17211" txt_f="17213">41</offsets></xref></sup></p><p><offsets xml_i="26470" xml_f="26570" txt_i="17214" txt_f="17314">There is evidence that many post stroke patients do not use their paretic hand spontaneously due to </offsets><italic><offsets xml_i="26578" xml_f="26593" txt_i="17314" txt_f="17329">learned non-use</offsets></italic><offsets xml_i="26602" xml_f="26603" txt_i="17329" txt_f="17330">.</offsets><sup><xref rid="ref50" ref-type="bibr"><offsets xml_i="26642" xml_f="26644" txt_i="17330" txt_f="17332">50</offsets></xref><offsets xml_i="26651" xml_f="26652" txt_i="17332" txt_f="17333">,</offsets><xref rid="ref51" ref-type="bibr"><offsets xml_i="26686" xml_f="26688" txt_i="17333" txt_f="17335">51</offsets></xref></sup><offsets xml_i="26701" xml_f="26817" txt_i="17335" txt_f="17451"> The detected benefits in the FMA were partially but still meaningfully sustained after six months, although in CIMT</offsets><sub><offsets xml_i="26822" xml_f="26833" txt_i="17451" txt_f="17462">1.5h_direct</offsets></sub><offsets xml_i="26839" xml_f="26989" txt_i="17462" txt_f="17612"> results did not reached statistical significance. FMA is a laboratory test that assesses motor function, showing what patients can do when requested.</offsets></p><p><offsets xml_i="26996" xml_f="27242" txt_i="17613" txt_f="17859">Although CIMT protocols results in improved function it is not clear whether CIMT is necessary to reach the results reported in several studies or whether exposure to task-specific and high-intensity training are the main components for recovery.</offsets><sup><xref rid="ref52" ref-type="bibr"><offsets xml_i="27281" xml_f="27283" txt_i="17859" txt_f="17861">52</offsets></xref><offsets xml_i="27290" xml_f="27291" txt_i="17861" txt_f="17862">,</offsets><xref rid="ref53" ref-type="bibr"><offsets xml_i="27325" xml_f="27327" txt_i="17862" txt_f="17864">53</offsets></xref></sup><offsets xml_i="27340" xml_f="27355" txt_i="17864" txt_f="17879"> Recently Taub </offsets><italic><offsets xml_i="27363" xml_f="27369" txt_i="17879" txt_f="17885">et al.</offsets></italic><sup><xref rid="ref54" ref-type="bibr"><offsets xml_i="27417" xml_f="27419" txt_i="17885" txt_f="17887">54</offsets></xref></sup><offsets xml_i="27432" xml_f="27464" txt_i="17887" txt_f="17919"> discussed the relevance of the </offsets><italic><offsets xml_i="27472" xml_f="27488" txt_i="17919" txt_f="17935">transfer package</offsets></italic><offsets xml_i="27497" xml_f="28062" txt_i="17935" txt_f="18500"> that is a set of techniques to help transfer of therapeutic gains from laboratory to real life. The study concluded that the transfer package seems to be an important element of CIMT protocols increasing real-world treatment outcomes. The present study applied some principles of the transfer package like written assignment of practice at home, daily home diary and problem solving strategies to increase arm use in ADL. Health-related quality of life (HRQOL) is a multidimensional concept and can be impacted by several factors besides physical or mental status.</offsets><sup><xref rid="ref55" ref-type="bibr"><offsets xml_i="28101" xml_f="28103" txt_i="18500" txt_f="18502">55</offsets></xref></sup><offsets xml_i="28116" xml_f="28173" txt_i="18502" txt_f="18559"> A Chinese study with chronic stroke patients found that </offsets><italic><offsets xml_i="28181" xml_f="28202" txt_i="18559" txt_f="18580">having a lower income</offsets></italic><offsets xml_i="28211" xml_f="28271" txt_i="18580" txt_f="18640"> was the strongest predicting variable for low HRQOL scores.</offsets><sup><xref rid="ref56" ref-type="bibr"><offsets xml_i="28310" xml_f="28312" txt_i="18640" txt_f="18642">56</offsets></xref></sup><offsets xml_i="28325" xml_f="28541" txt_i="18642" txt_f="18858"> The effect of exercises on HRQOL in stroke survivors is not fully studied. A recent meta-analysis showed small to medium effects of exercises in HRQOL outcomes after intervention but not 12 to 24 weeks at follow-up.</offsets><sup><xref rid="ref57" ref-type="bibr"><offsets xml_i="28580" xml_f="28582" txt_i="18858" txt_f="18860">57</offsets></xref></sup><offsets xml_i="28595" xml_f="28796" txt_i="18860" txt_f="19061"> In the present study, the absence of significant differences in EI for the SSQOL may be related to the small sample size, because within-group analysis showed significant improvements only in the CIMT</offsets><sub><offsets xml_i="28801" xml_f="28803" txt_i="19061" txt_f="19063">3h</offsets></sub><offsets xml_i="28809" xml_f="28810" txt_i="19063" txt_f="19064">
</offsets><sub><offsets xml_i="28815" xml_f="28820" txt_i="19064" txt_f="19069">group</offsets></sub><offsets xml_i="28826" xml_f="28827" txt_i="19069" txt_f="19070">.</offsets></p><p><offsets xml_i="28834" xml_f="29427" txt_i="19071" txt_f="19664">The limitations of the present study are related to its small sample size and to the absence of a control group not receiving CIMT. Strict study criteria akin to those of EXCITE led to the inclusion of only 13.8% of screened subjects. Hence, our results should necessarily be considered preliminary. Future trials should involve a larger number of participants. This should allow investigating the ideal amount of daily training and the influence of each CIMT element in functional recovery. In conclusion, our modified CIMT protocols were feasible and well tolerated. Results in bothCIMT1.5h_</offsets><sub><offsets xml_i="29432" xml_f="29438" txt_i="19664" txt_f="19670">direct</offsets></sub><offsets xml_i="29444" xml_f="29459" txt_i="19670" txt_f="19685"> group and CIMT</offsets><sub><offsets xml_i="29464" xml_f="29473" txt_i="19685" txt_f="19694">3h_direct</offsets></sub><offsets xml_i="29479" xml_f="29930" txt_i="19694" txt_f="20145"> group were associated with similar improvements in real world arm use after stroke. As protocols involving less therapist supervision can reduce treatment costs, these results, if confirmed, could lead to a wider dissemination of CIMT as a standard treatment in large numbers of stroke survivors. This would be of special importance in developing countries, which should be prepared to take a greater part of the expected stroke burden in the future.</offsets></p></sec></body><back><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feigin</surname><given-names>VL</given-names></name><name><surname>Lawes</surname><given-names>CMM</given-names></name><name><surname>Benett</surname><given-names>DA</given-names></name><name><surname>Anderson</surname><given-names>CS</given-names></name></person-group>
<article-title>Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the last 20th century</article-title>. <source>Lancet Neurol</source>
<year>2003</year>;<volume>2</volume>:<fpage>43</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">12849300</pub-id></mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gresham</surname><given-names>GE</given-names></name><name><surname>Alexander</surname><given-names>D</given-names></name><name><surname>Bishop</surname><given-names>DS</given-names></name><etal></etal></person-group>
<article-title>American Heart Association prevention conference. IV. Prevention and rehabilitation of stroke. Rehabilitation</article-title>. <source>Stroke</source>
<year>1997</year>;<volume>28</volume>:<fpage>1522</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">9227710</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarti</surname><given-names>C</given-names></name><name><surname>Rastenyte</surname><given-names>D</given-names></name><name><surname>Cepaitis</surname><given-names>Z</given-names></name><name><surname>Tuomiletho</surname><given-names>J</given-names></name></person-group>
<article-title>International trends in mortality from stroke, 1968–1994</article-title>. <source>Stroke</source>
<year>2000</year>;<volume>31</volume>:<fpage>1588</fpage>–<lpage>601</lpage>.<pub-id pub-id-type="pmid">10884459</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curioni</surname><given-names>C</given-names></name><name><surname>Cunha</surname><given-names>CB</given-names></name><name><surname>Veras</surname><given-names>RP</given-names></name><name><surname>Andre</surname><given-names>C</given-names></name></person-group>
<article-title>The decline in mortality from circulatory diseases in Brazil</article-title>. <source>Rev Panam Salud Publica</source>
<year>2009</year>;<volume>25</volume>:<fpage>9</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">19341518</pub-id></mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabral</surname><given-names>NL</given-names></name><name><surname>Gonçalves</surname><given-names>ARR</given-names></name><name><surname>Longo</surname><given-names>AL</given-names></name><etal></etal></person-group>
<article-title>Trends in stroke incidence, mortality and cases fatality rates in Joinville, Brazil: 1995–2006</article-title>. <source>J Neurol Neurosurg Psychiatry</source>
<year>2009</year>;<volume>80</volume>:<fpage>749</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">19147630</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>LV</given-names></name><name><surname>Taub</surname><given-names>E</given-names></name><name><surname>Mark</surname><given-names>VW</given-names></name><etal></etal></person-group>
<article-title>Improvement after constraint induced movement therapy is independent of infarct location in chronic stroke patients: supplemental methods</article-title>. <source>Stroke</source>
<year>2009</year>;<volume>40</volume>:<fpage>2468</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">19461024</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwakkel</surname><given-names>G</given-names></name><name><surname>Kollen</surname><given-names>BJ</given-names></name><name><surname>van der Grond</surname><given-names>J</given-names></name><name><surname>Prevo</surname><given-names>AJ</given-names></name></person-group>
<article-title>Probability of regaining dexterity in the flaccid upper limb. Impact of severity of paresis and time since acute stroke</article-title>. <source>Stroke</source>
<year>2003</year>;<volume>34</volume>:<fpage>2181</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">12907818</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>RL</given-names></name></person-group>
<article-title>Improving post stroke recovery: neuroplasticity and task-oriented training</article-title>. <source>Curr Treat Opt Cardiovascul Med</source>
<year>2009</year>;<volume>11</volume>:<fpage>251</fpage>–<lpage>9</lpage>.</mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname><given-names>E</given-names></name><name><surname>Miller</surname><given-names>NE</given-names></name><name><surname>Novack</surname><given-names>TA</given-names></name></person-group>
<article-title>Technique to improve chronic motor deficit after stroke</article-title>. <source>Arch Phys Med Rehabil</source>
<year>1993</year>;<volume>74</volume>:<fpage>347</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">8466415</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname><given-names>E</given-names></name><name><surname>Crago</surname><given-names>JE</given-names></name><name><surname>Uswatte</surname><given-names>G</given-names></name></person-group>
<article-title>Constraint-induced movement therapy: a new approach to treatment in physical medicine</article-title>. <source>Rehabil Psychol</source>
<year>1998</year>;<volume>43</volume>:<fpage>152</fpage>–<lpage>70</lpage>.</mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Lee</surname><given-names>JH</given-names></name><name><surname>Wagenaar</surname><given-names>RC</given-names></name><name><surname>Lankhorst</surname><given-names>GJ</given-names></name><etal></etal></person-group>
<article-title>Forced use of the upper extremity in chronic stroke patients</article-title>. <source>Stroke</source>
<year>1999</year>;<volume>30</volume>:<fpage>2369</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">10548673</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winstein</surname><given-names>CJ</given-names></name><name><surname>Miller</surname><given-names>JP</given-names></name><name><surname>Blanton</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Methods for a multisite randomized trial to investigate the effect of constraint-induced movement therapy in improving upper extremity function among adults recovering from a cerebrovascular stroke</article-title>. <source>Neurorehabil Neural Repair</source>
<year>2003</year>;<volume>17</volume>:<fpage>137</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">14503435</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>SL</given-names></name><name><surname>Winstein</surname><given-names>CJ</given-names></name><name><surname>Miller</surname><given-names>JP</given-names></name><etal></etal></person-group>
<article-title>Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial</article-title>. <source>JAMA</source>
<year>2006</year>;<volume>296</volume>:<fpage>2095</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="pmid">17077374</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>DPK</given-names></name><name><surname>Ng</surname><given-names>AKY</given-names></name><name><surname>Fong</surname><given-names>KNK</given-names></name></person-group>
<article-title>Effect of modified constraint-induced movement therapy for clients with chronic stroke in a community setting</article-title>. <source>Human Mov Sci</source>
<year>2009</year>;<volume>28</volume>:<fpage>798</fpage>–<lpage>808</lpage>.<pub-id pub-id-type="pmid">19837473</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>SJ</given-names></name><name><surname>Sisto</surname><given-names>S</given-names></name><name><surname>Levine</surname><given-names>P</given-names></name><name><surname>McGrath</surname><given-names>RE</given-names></name></person-group>
<article-title>Efficacy of modified constraint – induced movement therapy in chronic stroke: a single- blinded randomized controlled trial</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2004</year>;<volume>85</volume>:<fpage>14</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">14970962</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>SJ</given-names></name><name><surname>Levine</surname><given-names>P</given-names></name><name><surname>Leonard</surname><given-names>AC</given-names></name></person-group>
<article-title>Modified constraint-induced therapy in acute stroke: a randomized controlled pilot study</article-title>. <source>Neurorehabil Neural Repair</source>
<year>2005</year>;<volume>19</volume>:<fpage>27</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">15673841</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boake</surname><given-names>C</given-names></name><name><surname>Noser</surname><given-names>EA</given-names></name><name><surname>Ro</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Constraint-induced movement therapy during early stroke rehabilitation</article-title>. <source>Neurorehabil Neural Repair</source>
<year>2007</year>;<volume>21</volume>:<fpage>14</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">17172550</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>SJ</given-names></name><name><surname>Levine</surname><given-names>P</given-names></name><name><surname>Leonard</surname><given-names>AC</given-names></name><etal></etal></person-group>
<article-title>Modified constraint-induced movement therapy in chronic stroke: results of a single-blinded randomized controlled trial</article-title>. <source>Phys Ther</source>
<year>2008</year>;<volume>88</volume>:<fpage>333</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">18174447</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>CY</given-names></name><name><surname>Lin</surname><given-names>KC</given-names></name><name><surname>Chen</surname><given-names>CL</given-names></name><etal></etal></person-group>
<article-title>A randomized controlled trial of modified constraint-induced movement therapy for elderly stroke survivors: changes in motor impairment, daily functioning, and quality of life</article-title>. <source>Arc Phys Med Rehabil</source>
<year>2007</year>;<volume>88</volume>:<fpage>273</fpage>–<lpage>8</lpage>.</mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folstein</surname><given-names>MF</given-names></name><name><surname>Folstein</surname><given-names>SE</given-names></name><name><surname>McHugh</surname><given-names>PR</given-names></name></person-group>
<article-title>Mini-mental state: a practical method for grading the cognitive state of patients for the clinician</article-title>. <source>J Psychiatric Res</source>
<year>1975</year>;<volume>12</volume>:<fpage>189</fpage>–<lpage>98</lpage>.</mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohannon</surname><given-names>RW</given-names></name><name><surname>Smith</surname><given-names>MB</given-names></name></person-group>
<article-title>Interrater reliability of a modified Ashworth scale of muscle spasticity</article-title>. <source>Phys Ther</source>
<year>1987</year>;<volume>67</volume>:<fpage>206</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">3809245</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname><given-names>E</given-names></name><name><surname>Uswatte</surname><given-names>G</given-names></name><name><surname>King</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>A placebo controlled trial of constraint induced movement therapy for upper extremity after stroke</article-title>. <source>Stroke</source>
<year>2006</year>;<volume>37</volume>:<fpage>1039</fpage>–<lpage>45</lpage>.</mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname><given-names>E</given-names></name><name><surname>Uswatte</surname><given-names>G</given-names></name><name><surname>Pidikiti</surname><given-names>R</given-names></name></person-group>
<article-title>Constraint-induced movement therapy: a new family of techniques with broad application to physical rehabilitation: a clinical review</article-title>. <source>J Rehabil Res Dev</source>
<year>1999</year>;<volume>36</volume>:<fpage>237</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">10659807</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uswatte</surname><given-names>G</given-names></name><name><surname>Taub</surname><given-names>E</given-names></name><name><surname>Morris</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Reliability and validity of the upper-extremity Motor Activity Log-14 for measuring real-world arm use</article-title>. <source>Stroke</source>
<year>2005</year>;<volume>36</volume>:<fpage>2493</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">16224078</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>AM</given-names></name><name><surname>Lindmark</surname><given-names>B</given-names></name></person-group>
<article-title>Responsiveness and validity of the motor activity log in patients during the subacute phase after stroke</article-title>. <source>Disabil Rehabil</source>
<year>2010</year>;<volume>32</volume>:<fpage>1184</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">20128630</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanford</surname><given-names>J</given-names></name><name><surname>Moreland</surname><given-names>J</given-names></name><name><surname>Swanson</surname><given-names>LR</given-names></name><etal></etal></person-group>
<article-title>Reliability of the Fugl-Meyer assessment for testing motor performance in patients following stroke</article-title>. <source>Phys Ther</source>
<year>1993</year>;<volume>73</volume>:<fpage>448</fpage>–<lpage>54</lpage>.</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladstone</surname><given-names>DJ</given-names></name><name><surname>Danells</surname><given-names>CJ</given-names></name><name><surname>Black</surname><given-names>SE</given-names></name></person-group>
<article-title>The Fugal-Meyer assessment of motor recovery after stroke: a critical review of its measurement properties</article-title>. <source>Neurorehabil Neural Repair</source>
<year>2002</year>;<volume>16</volume>:<fpage>232</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">12234086</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maki</surname><given-names>T</given-names></name><name><surname>Quagliato</surname><given-names>EMAB</given-names></name><name><surname>Cacho</surname><given-names>EWA</given-names></name><etal></etal></person-group>
<article-title>Estudo de confiabilidade da aplicação da escala de Fulg-Meyer no Brasil</article-title>. <source>Rev Bras Fisioter</source>
<year>2006</year>;<volume>10</volume>;<fpage>177</fpage>–<lpage>83</lpage>.</mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>LS</given-names></name><name><surname>Weinberger</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>L</given-names></name><name><surname>Biller</surname><given-names>J</given-names></name></person-group>
<article-title>Measuring quality of life in a way that is meaningful to stroke patients</article-title>. <source>Neurology</source>
<year>1999</year>;<volume>53</volume>:<fpage>1839</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">10563636</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>LS</given-names></name><name><surname>Weinberger</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Development of a stroke-specific quality of life scale</article-title>. <source>Stroke</source>
<year>1999</year>;<volume>30</volume>:<fpage>1362</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">10390308</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>RCM</given-names></name><name><surname>Teixeira-Salmela</surname><given-names>LP</given-names></name><name><surname>Magalhães</surname><given-names>LC</given-names></name><name><surname>Gomes-Neto</surname><given-names>M</given-names></name></person-group>
<article-title>Propriedades psicométricas da versão brasileira da escala de qualidade de vida específica para acidente vascular encefálico: aplicação do modelo Rasch</article-title>. <source>Rev Bras Fisioter</source>
<year>2008</year>;<volume>12</volume>:<fpage>149</fpage>–<lpage>56</lpage>.</mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>TH</given-names></name></person-group>
<article-title>International classification of functioning, disability and health: an introduction and discussion of its potential impact on rehabilitation services and research</article-title>. <source>J Rehabil Med</source>
<year>2002</year>;<volume>34</volume>:<fpage>201</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">12392233</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>KC</given-names></name><name><surname>Chung</surname><given-names>HY</given-names></name><name><surname>Wu</surname><given-names>CY</given-names></name><etal></etal></person-group>
<article-title>Constraint-induced movement therapy versus control intervention in patients with stroke</article-title>. <source>Am J Phys Med Rehabil</source>
<year>2010</year>;<volume>89</volume>:<fpage>177</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">20173425</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Vanclay</surname><given-names>F</given-names></name><name><surname>Cooper</surname><given-names>B</given-names></name></person-group>
<article-title>Efficiency, effectiveness and duration of stroke rehabilitation</article-title>. <source>Stroke</source>
<year>1990</year>;<volume>21</volume>:<fpage>241</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">2305399</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klugler</surname><given-names>C</given-names></name><name><surname>Altenhöner</surname><given-names>T</given-names></name><name><surname>Lochner</surname><given-names>P</given-names></name><name><surname>Ferbert</surname><given-names>A</given-names></name></person-group>
<article-title>Does age influence early recovery from ischemic stroke?</article-title>
<source>J Neurol</source>
<year>2003</year>;<volume>250</volume>:<fpage>676</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">12796828</pub-id></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname><given-names>E</given-names></name><name><surname>Lum</surname><given-names>PS</given-names></name><name><surname>Hardin</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>AutoCITE: automated delivery of CI therapy with reduced effort by therapists</article-title>. <source>Stroke</source>
<year>2005</year>;<volume>36</volume>:<fpage>1301</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">15879335</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>L</given-names></name><name><surname>Rothi</surname><given-names>LJG</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Limited dose response to constraint-induced movement therapy in patients with chronic stroke</article-title>. <source>Clin Rehabil</source>
<year>2006</year>;<volume>20</volume>:<fpage>1066</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">17148518</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barzel</surname><given-names>A</given-names></name><name><surname>Liepert</surname><given-names>J</given-names></name><name><surname>Haevernick</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>Comparison of two types of constraint-induced movement therapy in chronic stroke patients: a pilot study</article-title>. <source>Res Neurol Neurosci</source>
<year>2009</year>;<volume>27</volume>:<fpage>673</fpage>–<lpage>80</lpage>.</mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>SJ</given-names></name><name><surname>Levine</surname><given-names>P</given-names></name><name><surname>Sisto</surname><given-names>S</given-names></name></person-group>
<article-title>Stroke patient’s and therapist’s opinions of constraint-induced movement therapy</article-title>. <source>Clin Rehabil</source>
<year>2002</year>;<volume>16</volume>:<fpage>55</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">11837526</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>KC</given-names></name><name><surname>Wu</surname><given-names>CY</given-names></name><name><surname>Wei</surname><given-names>TH</given-names></name><etal></etal></person-group>
<article-title>Effects of modified constraint-induced movement therapy on reach-to-grasp movements and functional performance after chronic stroke: a randomized controlled trial</article-title>. <source>Clin Rehabil</source>
<year>2007</year>;<volume>21</volume>:<fpage>1075</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">18042603</pub-id></mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterr</surname><given-names>A</given-names></name><name><surname>Elbert</surname><given-names>T</given-names></name><name><surname>Berthold</surname><given-names>I</given-names></name><etal></etal></person-group>
<article-title>Longer versus shorter daily constraint-induced movement therapy of chronic hemiparesis: an exploratory study</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2002</year>;<volume>83</volume>:<fpage>1374</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">12370871</pub-id></mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittenberg</surname><given-names>GF</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Ishii</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>Constraint-induced therapy in stroke: magnetic-stimulation motor maps and cerebral activation</article-title>. <source>Neurorehabil Neural Repair</source>
<year>2003</year>;<volume>17</volume>:<fpage>48</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">12645445</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>SL</given-names></name><name><surname>Thompson</surname><given-names>PA</given-names></name><name><surname>Winstein</surname><given-names>CJ</given-names></name><etal></etal></person-group>
<article-title>The EXCITE stroke trial, comparing early and delayed constraint-induced movement therapy</article-title>. <source>Stroke</source>
<year>2010</year>;<volume>41</volume>:<fpage>2309</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">20814005</pub-id></mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>K</given-names></name></person-group>
<article-title>Constraint-induced movement therapy for people following stroke in an outpatient setting</article-title>. <source>NZ J Phys</source>
<year>2004</year>;<volume>32</volume>:<fpage>111</fpage>–<lpage>9</lpage>.</mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterr</surname><given-names>A</given-names></name><name><surname>Saunders</surname><given-names>A</given-names></name></person-group>
<article-title>CI therapy distribution: theory, evidence and practice</article-title>. <source>Neurorehabil</source>
<year>2006</year>;<volume>21</volume>:<fpage>97</fpage>–<lpage>105</lpage>.</mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brogärdh</surname><given-names>C</given-names></name><name><surname>Vestiling</surname><given-names>M</given-names></name><name><surname>Sjölund</surname><given-names>BH</given-names></name></person-group>
<article-title>A 1 year follow-up after shortened constraint-induced movement therapy with and without mitt poststroke</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2010</year>;<volume>91</volume>:<fpage>460</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">20298840</pub-id></mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawczyk</surname><given-names>M</given-names></name><name><surname>Sidaway</surname><given-names>M</given-names></name><name><surname>Radwanska</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Effects of sling and voluntary constraint during CIMT for the arm after stroke: a randomized, prospective, single-centre, blinded observer rated study</article-title>. <source>Clin Rehabil</source>
<year>2012</year>;<volume>26</volume>:<fpage>990</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">22584730</pub-id></mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>SL</given-names></name><name><surname>George</surname><given-names>SZ</given-names></name><name><surname>Wolf</surname><given-names>SL</given-names></name><name><surname>Ligth</surname><given-names>KE</given-names></name></person-group>
<article-title>Participant perception of recovery as criterion to establish importance of improvement for CIMT outcome measures: a preliminary study</article-title>. <source>Phys Ther</source>
<year>2007</year>;<volume>87</volume>:<fpage>170</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">17244694</pub-id></mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SW</given-names></name><name><surname>Wolf</surname><given-names>SL</given-names></name><name><surname>Blanton</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>The EXCITE trial: predicting a clinically meaningful motor activity log outcome</article-title>. <source>Neurorehabil Neural Repair</source>
<year>2008</year>;<volume>22</volume>:<fpage>486</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">18780883</pub-id></mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterr</surname><given-names>A</given-names></name><name><surname>Freivogel</surname><given-names>S</given-names></name><name><surname>Schmalohr</surname><given-names>D</given-names></name></person-group>
<article-title>Neurobehavioral aspects of recovery: assessment of the learned nonuse phenomenon in hemiparetic adolescents</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2002</year>;<volume>83</volume>:<fpage>1726</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">12474177</pub-id></mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uswatte</surname><given-names>G</given-names></name><name><surname>Taub</surname><given-names>E</given-names></name></person-group>
<article-title>Implications of the learned non use formulation for measuring reabilitations outcomes: lessons from CIMT</article-title>. <source>Rehabil Psychol</source>
<year>2002</year>;<volume>50</volume>:<fpage>34</fpage>–<lpage>42</lpage>.</mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viana</surname><given-names>R</given-names></name><name><surname>Teasell</surname><given-names>R</given-names></name></person-group>
<article-title>Barriers to the implementation of constraint-induced movement therapy into practice</article-title>. <source>Tops Stroke Rehabil</source>
<year>2012</year>;<volume>19</volume>:<fpage>104</fpage>–<lpage>14</lpage>.</mixed-citation></ref><ref id="ref53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterr</surname><given-names>A</given-names></name><name><surname>Saunders</surname><given-names>A</given-names></name></person-group>
<article-title>CI therapy distribution: theory, evidence and practice</article-title>. <source>Neurorehabil</source>
<year>2006</year>;<volume>21</volume>:<fpage>97</fpage>–<lpage>105</lpage>.</mixed-citation></ref><ref id="ref54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname><given-names>E</given-names></name><name><surname>Uswatte</surname><given-names>G</given-names></name><name><surname>Mark</surname><given-names>VW</given-names></name><etal></etal></person-group>
<article-title>Method for enhancing real-world use or a more affected arm in chronic stroke. Transfer package of constraint-induced movement therapy</article-title>. <source>Stroke</source>
<year>2013</year>;<volume>44</volume>:<fpage>1383</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">23520237</pub-id></mixed-citation></ref><ref id="ref55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carod-Artal</surname><given-names>FJ</given-names></name><name><surname>Egidio</surname><given-names>JA</given-names></name></person-group>
<article-title>Quality of life after stroke: the importance of a good recovery</article-title>. <source>Cerebrovasc Dis</source>
<year>2009</year>;<volume>27</volume>:<fpage>204</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">19342853</pub-id></mixed-citation></ref><ref id="ref56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delcourt</surname><given-names>C</given-names></name><name><surname>Hackett</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Determinants of quality of life after stroke in China- the ChinaQuest (quality evaluation of stroke care and treatment) study</article-title>. <source>Stroke</source>
<year>2011</year>;<volume>42</volume>:<fpage>433</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">21183752</pub-id></mixed-citation></ref><ref id="ref57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>MD</given-names></name><name><surname>Rimmer</surname><given-names>JH</given-names></name></person-group>
<article-title>Effects of exercises on quality of life in stroke survivors: a meta-analysis</article-title>. <source>Stroke</source>
<year>2011</year>;<volume>42</volume>:<fpage>827</fpage>–<lpage>32</lpage>.</mixed-citation></ref></ref-list></back><floats-group><fig id="fig001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Flowchart of participants through the study.</p></caption><graphic xlink:href="ni-2015-1-5430-g001"></graphic></fig><fig id="fig002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Effectiveness indexes results regarding Motor Activity Log (A), Fugl-Meyer Assessment (B) and Stroke Specific Quality of Life (C) scores between CMIT<sub>1.5h_direct</sub> group and CIMT<sub>3h_direct</sub> group pre-to-post treatment and pre-to-6 months after treatment. Mann Whitney Test (P&lt;0.025). NS, not statistically significant.</p></caption><graphic xlink:href="ni-2015-1-5430-g002"></graphic></fig><table-wrap id="table001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Characteristics of study participants.</p></caption><table frame="box" rules="all"><thead><tr><th align="left" rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">CIMT 1.5h_direct</th><th align="center" rowspan="1" colspan="1">CIMT 3h_direct</th><th align="center" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, years, means (SD)<xref ref-type="table-fn" rid="table001-tfn1">*</xref></td><td align="center" rowspan="1" colspan="1">61.7 (12.7)</td><td align="center" rowspan="1" colspan="1">59.5 (9.1)</td><td align="center" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender (men/women)<xref ref-type="table-fn" rid="table001-tfn2">**</xref></td><td align="center" rowspan="1" colspan="1">6/3</td><td align="center" rowspan="1" colspan="1">9/1</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">Months after stroke, mean (SD)<xref ref-type="table-fn" rid="table001-tfn1">*</xref></td><td align="center" rowspan="1" colspan="1">27.6 (20.9)</td><td align="center" rowspan="1" colspan="1">35.3 (33.8)</td><td align="center" rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" rowspan="1" colspan="1">Type of stroke (ischemic/hemorrhagic)<xref ref-type="table-fn" rid="table001-tfn2">**</xref></td><td align="center" rowspan="1" colspan="1">7/2</td><td align="center" rowspan="1" colspan="1">7/3</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">Handedness (right/left)<xref ref-type="table-fn" rid="table001-tfn2">**</xref></td><td align="center" rowspan="1" colspan="1">7/2</td><td align="center" rowspan="1" colspan="1">9/1</td><td align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" rowspan="1" colspan="1">Years of education<xref ref-type="table-fn" rid="table001-tfn1">*</xref></td><td align="center" rowspan="1" colspan="1">5.0 (1.7)</td><td align="center" rowspan="1" colspan="1">6.6 (3.2)</td><td align="center" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" rowspan="1" colspan="1">Affected hemisphere (right/left)<xref ref-type="table-fn" rid="table001-tfn2">**</xref></td><td align="center" rowspan="1" colspan="1">4/5</td><td align="center" rowspan="1" colspan="1">4/6</td><td align="center" rowspan="1" colspan="1">0.60</td></tr><tr><td align="left" rowspan="1" colspan="1">Motor Activity Log<xref ref-type="table-fn" rid="table001-tfn1">*</xref></td><td align="center" rowspan="1" colspan="1">1.2 (0.8)</td><td align="center" rowspan="1" colspan="1">0.7 (0.5)</td><td align="center" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke Specific Quality of Life Scale<xref ref-type="table-fn" rid="table001-tfn1">*</xref></td><td align="center" rowspan="1" colspan="1">163.1 (39.3)</td><td align="center" rowspan="1" colspan="1">143.3 (25.3)</td><td align="center" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Fugl-Meyer assessment<xref ref-type="table-fn" rid="table001-tfn1">*</xref></td><td align="center" rowspan="1" colspan="1">53.4 (10.8)</td><td align="center" rowspan="1" colspan="1">51.4 (8.6)</td><td align="center" rowspan="1" colspan="1">0.44</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean and standard deviation (SD);</p></fn><fn id="table001-tfn1"><p>*Mann-Whitney U test;</p></fn><fn id="table001-tfn2"><p>**Fisher’s Exact Test.</p></fn></table-wrap-foot></table-wrap></floats-group></article>